Myasthenia gravis and infectious disease

go back to reference Abreu C, Sarmento A, Magro F (2017) Screening, prophylaxis and counselling before the start of biological therapies: a practical approach focused on IBD patients. Dig Liver Dis 49:1289–1297CrossRefPubMed Abreu C, Sarmento A, Magro F (2017) Screening, prophylaxis and counselling before the start of biological therapies: a practical approach focused on IBD patients. Dig Liver Dis 49:1289–1297CrossRefPubMed

go back to reference Andersen JB, Heldal AT, Engeland A, Gilhus NE (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand 129:26–31CrossRef Andersen JB, Heldal AT, Engeland A, Gilhus NE (2014) Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurol Scand 129:26–31CrossRef

go back to reference Andersen JB, Owe JF, Engeland A, Gilhus NE (2014) Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study. Eur J Neurol 21:948–955CrossRefPubMedPubMedCentral Andersen JB, Owe JF, Engeland A, Gilhus NE (2014) Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study. Eur J Neurol 21:948–955CrossRefPubMedPubMedCentral

go back to reference Auriel E, Regev K, Dori A, Karni A (2011) Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve 43:893–894CrossRefPubMed Auriel E, Regev K, Dori A, Karni A (2011) Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance. Muscle Nerve 43:893–894CrossRefPubMed

go back to reference Bach JF (2012) The etiology of autoimmune diseases: the case of myasthenia gravis. Annals N Y Acad Sci 1274:33–39CrossRef Bach JF (2012) The etiology of autoimmune diseases: the case of myasthenia gravis. Annals N Y Acad Sci 1274:33–39CrossRef

go back to reference Barzago C, Lum J, Cavalcante P, Srinivasan KG, Faggiani E, Camera G, Bonanno S, Andreetta F, Antozzi C, Baggi F, Calogero RA, Bernasconi P, Mantegazza R, Mori L, Zolezzi F (2016) A novel infection- and inflammation(_)associated molecular signature in peripheral blood of myasthenia gravis patients. Immunobiology 221:1227–1236CrossRefPubMed Barzago C, Lum J, Cavalcante P, Srinivasan KG, Faggiani E, Camera G, Bonanno S, Andreetta F, Antozzi C, Baggi F, Calogero RA, Bernasconi P, Mantegazza R, Mori L, Zolezzi F (2016) A novel infection- and inflammation(_)associated molecular signature in peripheral blood of myasthenia gravis patients. Immunobiology 221:1227–1236CrossRefPubMed

go back to reference Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100CrossRefPubMed Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90–100CrossRefPubMed

go back to reference Bhattacharyya S, Darby R, Berkowitz AL (2014) Antibiotic-induced neurotoxicity. Current infectious disease reports 16 Bhattacharyya S, Darby R, Berkowitz AL (2014) Antibiotic-induced neurotoxicity. Current infectious disease reports 16

go back to reference Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22:1164–1169CrossRefPubMed Blum S, Lee D, Gillis D, McEniery DF, Reddel S, McCombe P (2015) Clinical features and impact of myasthenia gravis disease in Australian patients. J Clin Neurosci 22:1164–1169CrossRefPubMed

go back to reference Bonvalet M, Ollila HM, Ambati A, Mignot E (2017) Autoimmunity in narcolepsy. Curr Opin Pulm Med 23:522–529CrossRefPubMed Bonvalet M, Ollila HM, Ambati A, Mignot E (2017) Autoimmunity in narcolepsy. Curr Opin Pulm Med 23:522–529CrossRefPubMed

go back to reference Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dorner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P, Rituximab Consensus Expert C (2011) Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 70:909–920CrossRefPubMedPubMedCentral Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dorner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, van Vollenhoven RF, Emery P, Rituximab Consensus Expert C (2011) Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis 70:909–920CrossRefPubMedPubMedCentral

go back to reference Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P (2016) Increased expression of toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection. Immunobiology 221:516–527CrossRefPubMed Cavalcante P, Galbardi B, Franzi S, Marcuzzo S, Barzago C, Bonanno S, Camera G, Maggi L, Kapetis D, Andreetta F, Biasiucci A, Motta T, Giardina C, Antozzi C, Baggi F, Mantegazza R, Bernasconi P (2016) Increased expression of toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein–Barr virus infection. Immunobiology 221:516–527CrossRefPubMed

go back to reference Cavalcante P, Serafini B, Rosicarelli B, Maggi L, Barberis M, Antozzi C, Berrih-Aknin S, Bernasconi P, Aloisi F, Mantegazza R (2010) Epstein–Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 67:726–738PubMed Cavalcante P, Serafini B, Rosicarelli B, Maggi L, Barberis M, Antozzi C, Berrih-Aknin S, Bernasconi P, Aloisi F, Mantegazza R (2010) Epstein–Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 67:726–738PubMed

go back to reference Chahin S, Berger JR (2015) A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy. J Neurovirol 21:623–631CrossRefPubMed Chahin S, Berger JR (2015) A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy. J Neurovirol 21:623–631CrossRefPubMed

go back to reference Cheng DR, Barton R, Greenway A, Crawford NW (2016) Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines 15:1567–1574CrossRefPubMed Cheng DR, Barton R, Greenway A, Crawford NW (2016) Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Rev Vaccines 15:1567–1574CrossRefPubMed

go back to reference Christopoulos P, Fisch P (2016) Acquired T-cell immunodeficiency in thymoma patients. Crit Rev Immunol 36:315–327CrossRefPubMed Christopoulos P, Fisch P (2016) Acquired T-cell immunodeficiency in thymoma patients. Crit Rev Immunol 36:315–327CrossRefPubMed

go back to reference Csuka D, Czirjak L, Hobor R, Illes Z, Banati M, Rajczy K, Tordai A, Fust G (2013) Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis. Mol Immunol 54:453–456CrossRefPubMed Csuka D, Czirjak L, Hobor R, Illes Z, Banati M, Rajczy K, Tordai A, Fust G (2013) Effective humoral immunity against diphtheria and tetanus in patients with systemic lupus erythematosus or myasthenia gravis. Mol Immunol 54:453–456CrossRefPubMed

go back to reference Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study. Ann Rheum Dis 70:956–960CrossRefPubMedPubMedCentral Dixon WG, Kezouh A, Bernatsky S, Suissa S (2011) The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study. Ann Rheum Dis 70:956–960CrossRefPubMedPubMedCentral

go back to reference Eddy S, Wim R, Peter V, Tanja R, Jan T, Werner V (1999) Myasthenia gravis—another autoimmune disease associated with hepatitis C virus infection. Dig Dis Sci 44:186–189CrossRefPubMed Eddy S, Wim R, Peter V, Tanja R, Jan T, Werner V (1999) Myasthenia gravis—another autoimmune disease associated with hepatitis C virus infection. Dig Dis Sci 44:186–189CrossRefPubMed

go back to reference Fardet L, Petersen I, Nazareth I (2016) Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. Plos Med 13(5):e1002024. https://doi.org/10.1371/journal.pmed.1002024 CrossRefPubMedPubMedCentral Fardet L, Petersen I, Nazareth I (2016) Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. Plos Med 13(5):e1002024. https://​doi.​org/​10.​1371/​journal.​pmed.​1002024 CrossRefPubMedPubMedCentral

go back to reference Feldman CH, Marty FM, Winkelmayer WC, Guan HS, Franklin JM, Solomon DH, Costenbader KH, Kim SC (2017) Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications. Arthritis Rheumatol 69:387–397CrossRefPubMedPubMedCentral Feldman CH, Marty FM, Winkelmayer WC, Guan HS, Franklin JM, Solomon DH, Costenbader KH, Kim SC (2017) Comparative rates of serious infections among patients with systemic lupus erythematosus receiving immunosuppressive medications. Arthritis Rheumatol 69:387–397CrossRefPubMedPubMedCentral

go back to reference Friedman MA, Winthrop K (2016) Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol 28:330–336CrossRefPubMed Friedman MA, Winthrop K (2016) Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol 28:330–336CrossRefPubMed

go back to reference Gilhus NE (2017) Eculizumab: a treatment option for mysthenia gravis? Lancet Neurol 16:947–948CrossRefPubMed Gilhus NE (2017) Eculizumab: a treatment option for mysthenia gravis? Lancet Neurol 16:947–948CrossRefPubMed

go back to reference Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570–2581CrossRefPubMed Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570–2581CrossRefPubMed

go back to reference Gilhus NE, Nacu A, Andersen JB, Owe JF (2015) Myasthenia gravis and risks for comorbidity. Eur J Neurol 22:17–23CrossRefPubMed Gilhus NE, Nacu A, Andersen JB, Owe JF (2015) Myasthenia gravis and risks for comorbidity. Eur J Neurol 22:17–23CrossRefPubMed

go back to reference Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036CrossRefPubMed Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023–1036CrossRefPubMed

go back to reference Gui MC, Luo X, Lin J, Li Y, Zhang M, Zhang XF, Yang MS, Wang W, Bu BT (2015) Long-term outcome of 424 childhood-onset myasthenia gravis patients. J Neurol 262:823–830CrossRefPubMed Gui MC, Luo X, Lin J, Li Y, Zhang M, Zhang XF, Yang MS, Wang W, Bu BT (2015) Long-term outcome of 424 childhood-onset myasthenia gravis patients. J Neurol 262:823–830CrossRefPubMed

go back to reference Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49:472–479CrossRefPubMedPubMedCentral Guptill JT, Juel VC, Massey JM, Anderson AC, Chopra M, Yi JS, Esfandiari E, Buchanan T, Smith B, Atherfold P, Jones E, Howard JF (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49:472–479CrossRefPubMedPubMedCentral

go back to reference Holbro A, Jauch A, Lardinois D, Tzankov A, Dirnhofer S, Hess C (2012) High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 73:287–290CrossRefPubMed Holbro A, Jauch A, Lardinois D, Tzankov A, Dirnhofer S, Hess C (2012) High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol 73:287–290CrossRefPubMed

go back to reference Hung WL, Lin YH, Wang PY, Chang MH (2011) HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. Clin Neurol Neurosurg 113:672–674CrossRefPubMed Hung WL, Lin YH, Wang PY, Chang MH (2011) HIV-associated myasthenia gravis and impacts of HAART: one case report and a brief review. Clin Neurol Neurosurg 113:672–674CrossRefPubMed

go back to reference Jf B (2017) The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 111:1–16 Jf B (2017) The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol 111:1–16

go back to reference Jing F, Wei D, Wang D, Li N, Cui F, Yang F, Chen Z, Huang X (2013) Lack of Epstein–Barr virus infection in Chinese myasthenia gravis patients. Acta Neurol Scand 128:345–350PubMed Jing F, Wei D, Wang D, Li N, Cui F, Yang F, Chen Z, Huang X (2013) Lack of Epstein–Barr virus infection in Chinese myasthenia gravis patients. Acta Neurol Scand 128:345–350PubMed

go back to reference Jones SC, Sorbello A, Boucher RM (2011) Fluoroquinolone-associated myasthenia gravis exacerbation evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf 34:839–847CrossRefPubMed Jones SC, Sorbello A, Boucher RM (2011) Fluoroquinolone-associated myasthenia gravis exacerbation evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug Saf 34:839–847CrossRefPubMed

go back to reference Kakalacheva K, Maurer MA, Tackenberg B, Munz C, Willcox N, Lunemann JD (2011) Intrathymic Epstein–Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 70:508–514CrossRefPubMed Kakalacheva K, Maurer MA, Tackenberg B, Munz C, Willcox N, Lunemann JD (2011) Intrathymic Epstein–Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 70:508–514CrossRefPubMed

go back to reference Kalita J, Kohat AK, Misra UK (2014) Predictors of outcome of myasthenic crisis. Neurol Sci 35:1109–1114CrossRefPubMed Kalita J, Kohat AK, Misra UK (2014) Predictors of outcome of myasthenic crisis. Neurol Sci 35:1109–1114CrossRefPubMed

go back to reference Kanth KM, Solorzano GE, Goldman MD (2016) PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. Neurol Clin Pract 6:E17–E19CrossRefPubMedPubMedCentral Kanth KM, Solorzano GE, Goldman MD (2016) PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents. Neurol Clin Pract 6:E17–E19CrossRefPubMedPubMedCentral

go back to reference Kohling HL, Plummer SF, Marchesi JR, Davidge KS, Ludgate M (2017) The microbiota and autoimmunity: their role in thyroid autoimmune diseases. Clin Immunol 183:63–74CrossRefPubMed Kohling HL, Plummer SF, Marchesi JR, Davidge KS, Ludgate M (2017) The microbiota and autoimmunity: their role in thyroid autoimmune diseases. Clin Immunol 183:63–74CrossRefPubMed

go back to reference Le P, Rothberg MB (2017) Cost effectiveness of a shingles vaccine booster for currently vaccinated adults in the US. Am J Prev Med 53:829–836CrossRefPubMed Le P, Rothberg MB (2017) Cost effectiveness of a shingles vaccine booster for currently vaccinated adults in the US. Am J Prev Med 53:829–836CrossRefPubMed

go back to reference Leis AA, Szatmary G, Ross MA, Stokic DS (2014) West nile virus infection and myasthenia gravis. Muscle Nerve 49:26–29CrossRefPubMed Leis AA, Szatmary G, Ross MA, Stokic DS (2014) West nile virus infection and myasthenia gravis. Muscle Nerve 49:26–29CrossRefPubMed

go back to reference Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 286:9726–9736CrossRefPubMedPubMedCentral Liu IJ, Chiu CY, Chen YC, Wu HC (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem 286:9726–9736CrossRefPubMedPubMedCentral

go back to reference Liu XQ, Bian SN, Zhang YQ, Zhang LF, Yang QW, Wang P, Xu YC, Shi XC, Zhang Y, Chemaly RF (2016) The characteristics of patients with Mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis 16:750. https://doi.org/10.1186/s12879-016-2084-z CrossRefPubMedPubMedCentral Liu XQ, Bian SN, Zhang YQ, Zhang LF, Yang QW, Wang P, Xu YC, Shi XC, Zhang Y, Chemaly RF (2016) The characteristics of patients with Mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis 16:750. https://​doi.​org/​10.​1186/​s12879-016-2084-z CrossRefPubMedPubMedCentral

go back to reference Ma GK, Brensinger CM, Wu QF, Lewis JD (2017) Increasing incidence of multiply recurrent Clostridium difficile infection in the United States a cohort study. Ann Intern Med 167:152–158CrossRefPubMed Ma GK, Brensinger CM, Wu QF, Lewis JD (2017) Increasing incidence of multiply recurrent Clostridium difficile infection in the United States a cohort study. Ann Intern Med 167:152–158CrossRefPubMed

go back to reference Maniaol AH, Elsais A, Lorentzen AR, Owe JF, Viken MK, Saether H, Flam ST, Brathen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CME, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. Plos One 7(5):e36603. https://doi.org/10.1371/journal.pone.0036603 Maniaol AH, Elsais A, Lorentzen AR, Owe JF, Viken MK, Saether H, Flam ST, Brathen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CME, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. Plos One 7(5):e36603. https://​doi.​org/​10.​1371/​journal.​pone.​0036603

go back to reference Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875–884CrossRefPubMed Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875–884CrossRefPubMed

go back to reference Melamed RD, Khiabanian H, Rabadan R (2014) Data-driven discovery of seasonally linked diseases from an electronic health records system. BMC Bioinf 15 (Suppl 6):S3. https://doi.org/10.1186/1471-2105-15-S6-S3 CrossRef Melamed RD, Khiabanian H, Rabadan R (2014) Data-driven discovery of seasonally linked diseases from an electronic health records system. BMC Bioinf 15 (Suppl 6):S3. https://​doi.​org/​10.​1186/​1471-2105-15-S6-S3 CrossRef

go back to reference Meyer A, Levy Y (2011) Geoepidemiology of myasthenia gravis (vol 9, pg A383, 2010). Autoimmun Rev 10:811CrossRef Meyer A, Levy Y (2011) Geoepidemiology of myasthenia gravis (vol 9, pg A383, 2010). Autoimmun Rev 10:811CrossRef

go back to reference Meyer M, Hols AK, Liersch B, Leistner R, Gellert K, Schalke B, Marx A, Niedobitek G (2011) Lack of evidence for Epstein–Barr virus infection in myasthenia gravis thymus. Ann Neurol 70:515–518CrossRefPubMed Meyer M, Hols AK, Liersch B, Leistner R, Gellert K, Schalke B, Marx A, Niedobitek G (2011) Lack of evidence for Epstein–Barr virus infection in myasthenia gravis thymus. Ann Neurol 70:515–518CrossRefPubMed

go back to reference Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC (2017) Zika virus infection and myasthenia gravis: report of 2 cases. Neurology 88:1097–1098CrossRefPubMed Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC (2017) Zika virus infection and myasthenia gravis: report of 2 cases. Neurology 88:1097–1098CrossRefPubMed

go back to reference Morandi E, Jagessar SA, A‘t Hart B, Gran B (2017) EBV infection empowers human B cells for Autoimmunity: role of autophagy and relevance to multiple sclerosis. J Immunol 199:435–448CrossRefPubMed Morandi E, Jagessar SA, A‘t Hart B, Gran B (2017) EBV infection empowers human B cells for Autoimmunity: role of autophagy and relevance to multiple sclerosis. J Immunol 199:435–448CrossRefPubMed

go back to reference Munz C, Lunemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246–258CrossRefPubMedPubMedCentral Munz C, Lunemann JD, Getts MT, Miller SD (2009) Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol 9:246–258CrossRefPubMedPubMedCentral

go back to reference Niller HH, Wolf H, Ay E, Minarovits J (2011) Epigenetic dysregulation of Epstein–Barr virus latency and development of autoimmune disease. Adv Exp Med Biol 711:82–102 Niller HH, Wolf H, Ay E, Minarovits J (2011) Epigenetic dysregulation of Epstein–Barr virus latency and development of autoimmune disease. Adv Exp Med Biol 711:82–102

go back to reference O’Leary ST, Kimberlin DW (2017) Update from the advisory committee on immunization practices. J Pediatr Infect Dis Soc 6:311–316CrossRef O’Leary ST, Kimberlin DW (2017) Update from the advisory committee on immunization practices. J Pediatr Infect Dis Soc 6:311–316CrossRef

go back to reference Ordas I, Domenech E, Manosa M, Garcia-Sanchez V, Iglesias-Flores E, Penalva M, Canas-Ventura A, Merino O, Fernandez-Banares F, Gomollon F, Vera M, Gutierrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Munoz F, Aguirresarobe M, Munoz C, Fernandez L, Calvet X, Jimenez CE, Montoro MA, Mir A, De Castro ML, Garcia-Sepulcre MF, Bermejo F, Panes J, Esteve M, GETECCU ER (2017) Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA registry (1989–2013): a nationwide multicenter study. Am J Gastroenterol 112:1709–1718CrossRefPubMed Ordas I, Domenech E, Manosa M, Garcia-Sanchez V, Iglesias-Flores E, Penalva M, Canas-Ventura A, Merino O, Fernandez-Banares F, Gomollon F, Vera M, Gutierrez A, Garcia-Planella E, Chaparro M, Aguas M, Gento E, Munoz F, Aguirresarobe M, Munoz C, Fernandez L, Calvet X, Jimenez CE, Montoro MA, Mir A, De Castro ML, Garcia-Sepulcre MF, Bermejo F, Panes J, Esteve M, GETECCU ER (2017) Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA registry (1989–2013): a nationwide multicenter study. Am J Gastroenterol 112:1709–1718CrossRefPubMed

go back to reference Perrot X, Bernard N, Vial C, Antoine JC, Laurent H, Vial T, Confavreux C, Vukusic S (2006) Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment. Neurology 67:2256–2258CrossRefPubMed Perrot X, Bernard N, Vial C, Antoine JC, Laurent H, Vial T, Confavreux C, Vukusic S (2006) Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment. Neurology 67:2256–2258CrossRefPubMed

go back to reference Prelog M, Egli A, Zlamy M, Hirsch HH (2013) JC and BK polyomavirus-specific immunoglobulin G responses in patients thymectomized in early childhood. J Clin Virol 58:553–558CrossRefPubMed Prelog M, Egli A, Zlamy M, Hirsch HH (2013) JC and BK polyomavirus-specific immunoglobulin G responses in patients thymectomized in early childhood. J Clin Virol 58:553–558CrossRefPubMed

go back to reference Ramagopalan SV, Goldacre R, Skingsley A, Conlon C, Goldacre MJ (2013) Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med 11:97. https://doi.org/10.1186/1741-7015-11-97 CrossRefPubMedPubMedCentral Ramagopalan SV, Goldacre R, Skingsley A, Conlon C, Goldacre MJ (2013) Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med 11:97. https://​doi.​org/​10.​1186/​1741-7015-11-97 CrossRefPubMedPubMedCentral

go back to reference Ramos-Fransi A, Rojas-Garcia R, Segovia S, Marquez-Infante C, Pardo J, Coll-Canti J, Jerico I, Illa I, Myasthenia NMDESSG (2015) Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry. Eur J Neurol 22:1056–1061CrossRefPubMed Ramos-Fransi A, Rojas-Garcia R, Segovia S, Marquez-Infante C, Pardo J, Coll-Canti J, Jerico I, Illa I, Myasthenia NMDESSG (2015) Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry. Eur J Neurol 22:1056–1061CrossRefPubMed

go back to reference Randall KL (2016) Rituximab in autoimmune diseases. Aust Prescr 39:131–134CrossRefPubMedPubMedCentral Randall KL (2016) Rituximab in autoimmune diseases. Aust Prescr 39:131–134CrossRefPubMedPubMedCentral

go back to reference Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chio A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ (2015) A genome-wide association study of myasthenia gravis. JAMA Neurol 72:396–404CrossRefPubMedPubMedCentral Renton AE, Pliner HA, Provenzano C, Evoli A, Ricciardi R, Nalls MA, Marangi G, Abramzon Y, Arepalli S, Chong S, Hernandez DG, Johnson JO, Bartoccioni E, Scuderi F, Maestri M, Gibbs JR, Errichiello E, Chio A, Restagno G, Sabatelli M, Macek M, Scholz SW, Corse A, Chaudhry V, Benatar M, Barohn RJ, McVey A, Pasnoor M, Dimachkie MM, Rowin J, Kissel J, Freimer M, Kaminski HJ, Sanders DB, Lipscomb B, Massey JM, Chopra M, Howard JF, Koopman WJ, Nicolle MW, Pascuzzi RM, Pestronk A, Wulf C, Florence J, Blackmore D, Soloway A, Siddiqi Z, Muppidi S, Wolfe G, Richman D, Mezei MM, Jiwa T, Oger J, Drachman DB, Traynor BJ (2015) A genome-wide association study of myasthenia gravis. JAMA Neurol 72:396–404CrossRefPubMedPubMedCentral

go back to reference Romi F, Bo L, Skeie GO, Myking A, Aarli JA, Gilhus NE (2002) Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128:82–89CrossRefPubMed Romi F, Bo L, Skeie GO, Myking A, Aarli JA, Gilhus NE (2002) Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol 128:82–89CrossRefPubMed

go back to reference Romi F, Hong Y, Gilhus NE (2017) Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Curr Opin immunol 49:9–13CrossRefPubMed Romi F, Hong Y, Gilhus NE (2017) Pathophysiology and immunological profile of myasthenia gravis and its subgroups. Curr Opin immunol 49:9–13CrossRefPubMed

go back to reference Rostaing L, Malvezzi P (2016) Steroid-based therapy and risk of infectious complications. Plos Med 13(5):e1002025. https://doi.org/10.1371/journal.pmed.1002025 CrossRefPubMedPubMedCentral Rostaing L, Malvezzi P (2016) Steroid-based therapy and risk of infectious complications. Plos Med 13(5):e1002025. https://​doi.​org/​10.​1371/​journal.​pmed.​1002025 CrossRefPubMedPubMedCentral

go back to reference Salemi S, D’Amelio R (2010) Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol 29:270–314CrossRefPubMed Salemi S, D’Amelio R (2010) Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol 29:270–314CrossRefPubMed

go back to reference Schmidt SAJ, Vestergaard M, Baggesen LM, Pedersen L, Schonheyder HC, Sorensen HT (2017) Prevaccination epidemiology of herpes zoster in Denmark: quantification of occurrence and risk factors. Vaccine 35:5589–5596CrossRefPubMed Schmidt SAJ, Vestergaard M, Baggesen LM, Pedersen L, Schonheyder HC, Sorensen HT (2017) Prevaccination epidemiology of herpes zoster in Denmark: quantification of occurrence and risk factors. Vaccine 35:5589–5596CrossRefPubMed

go back to reference Sempowski GD, Thomasch JR, Gooding ME, Hale LP, Edwards LJ, Ciafaloni E, Sanders DB, Massey JM, Douek DC, Koup RA, Haynes BF (2001) Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 166:2808–2817CrossRefPubMed Sempowski GD, Thomasch JR, Gooding ME, Hale LP, Edwards LJ, Ciafaloni E, Sanders DB, Massey JM, Douek DC, Koup RA, Haynes BF (2001) Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis. J Immunol 166:2808–2817CrossRefPubMed

go back to reference Seok HY, Shin HY, Kim JK, Kim BJ, Oh J, Suh BC, Kim SY, Kang SY, Ahn SW, Bae JS, Kim BJ (2017) The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis. J Clin Neurol 13:325–330CrossRefPubMedPubMedCentral Seok HY, Shin HY, Kim JK, Kim BJ, Oh J, Suh BC, Kim SY, Kang SY, Ahn SW, Bae JS, Kim BJ (2017) The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis. J Clin Neurol 13:325–330CrossRefPubMedPubMedCentral

go back to reference Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 10:CD005590. https://doi.org/10.1002/14651858.CD005590.pub3 CrossRef Stern A, Green H, Paul M, Vidal L, Leibovici L (2014) Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. Cochrane Database Syst Rev 10:CD005590. https://​doi.​org/​10.​1002/​14651858.​CD005590.​pub3 CrossRef

go back to reference Strezova A, Godeaux O, Aggarwal N, Leroux-Roels G, Lopez-Fauqued M, Van Damme P, Vanden Abeele C, Vastiau I, Heineman TC, Lal H (2017) A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su. Vaccine 35:6700–6706CrossRefPubMed Strezova A, Godeaux O, Aggarwal N, Leroux-Roels G, Lopez-Fauqued M, Van Damme P, Vanden Abeele C, Vastiau I, Heineman TC, Lal H (2017) A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su. Vaccine 35:6700–6706CrossRefPubMed

go back to reference Strijbos E, Huijbers MG, van Es IE, Alleman I, van Ostaijen-ten Dam MM, Bakker J, van Zwet EW, Jol-van der Zijde CM, van Tol MD, Verschuuren JJ (2017) A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis. Vaccine 35:6290–6296CrossRefPubMed Strijbos E, Huijbers MG, van Es IE, Alleman I, van Ostaijen-ten Dam MM, Bakker J, van Zwet EW, Jol-van der Zijde CM, van Tol MD, Verschuuren JJ (2017) A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis. Vaccine 35:6290–6296CrossRefPubMed

go back to reference Stubgen JP (2010) Neuromuscular disorders associated with Hepatitis B vaccination. J Neurol Sci 292:1–4CrossRefPubMed Stubgen JP (2010) Neuromuscular disorders associated with Hepatitis B vaccination. J Neurol Sci 292:1–4CrossRefPubMed

go back to reference Sugimoto N, Nakajima A, Inoue E, Shidara K, Yamashita H, Mimori A, Tokuda H, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H (2017) Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatol Int 37:1871–1878CrossRefPubMed Sugimoto N, Nakajima A, Inoue E, Shidara K, Yamashita H, Mimori A, Tokuda H, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H (2017) Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatol Int 37:1871–1878CrossRefPubMed

go back to reference Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A (2017) Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J 10:461–469PubMed Trivin C, Tran A, Moulin B, Choukroun G, Gatault P, Courivaud C, Augusto JF, Ficheux M, Vigneau C, Thervet E, Karras A (2017) Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J 10:461–469PubMed

go back to reference Van Berkel MA, Twilla JD, England BS (2016) Emergency department management of a myasthenia gravis patient with community-acquired pneumonia: does initial antibiotic choice lead to cure or crisis? J Emerg Med 50:281–285CrossRefPubMed Van Berkel MA, Twilla JD, England BS (2016) Emergency department management of a myasthenia gravis patient with community-acquired pneumonia: does initial antibiotic choice lead to cure or crisis? J Emerg Med 50:281–285CrossRefPubMed

go back to reference Virot E, Duclos A, Adelaide L, Miailhes P, Hot A, Ferry T, Seve P (2017) Autoimmune diseases and HIV infection a cross-sectional study. Med 96(4):e5769. https://doi.org/10.1097/MD.0000000000005769 CrossRef Virot E, Duclos A, Adelaide L, Miailhes P, Hot A, Ferry T, Seve P (2017) Autoimmune diseases and HIV infection a cross-sectional study. Med 96(4):e5769. https://​doi.​org/​10.​1097/​MD.​0000000000005769​ CrossRef

go back to reference Wickramasekaran RN, Jewell MP, Sorvillo F, Kuo T (2017) The changing trends and profile of pneumocystosis mortality in the United States, 1999–2014. Mycoses 60:607–615CrossRefPubMed Wickramasekaran RN, Jewell MP, Sorvillo F, Kuo T (2017) The changing trends and profile of pneumocystosis mortality in the United States, 1999–2014. Mycoses 60:607–615CrossRefPubMed

go back to reference Withrock IC, Anderson SJ, Jefferson MA, McCormack GR, Mlynarczyk GSA, Nakama A, Lange JK, Berg CA, Acharya S, Stock ML, Lind MS, Luna KC, Kondru NC, Manne S, Patel BB, de la Rosa BM, Huang KP, Sharma S, Hu HZ, Kanuri SH, Carlson SA (2015) Genetic diseases conferring resistance to infectious diseases. Genes Dis 2:247–254CrossRef Withrock IC, Anderson SJ, Jefferson MA, McCormack GR, Mlynarczyk GSA, Nakama A, Lange JK, Berg CA, Acharya S, Stock ML, Lind MS, Luna KC, Kondru NC, Manne S, Patel BB, de la Rosa BM, Huang KP, Sharma S, Hu HZ, Kanuri SH, Carlson SA (2015) Genetic diseases conferring resistance to infectious diseases. Genes Dis 2:247–254CrossRef

go back to reference Wolfe GIKH, Aban IB, Minisman G et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511–522CrossRefPubMedPubMedCentral Wolfe GIKH, Aban IB, Minisman G et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511–522CrossRefPubMedPubMedCentral

go back to reference Wong PKK, Bagga H, Barrett C, Hanrahan P, Johnson D, Katrib A, Leder K, Marabani M, Pentony P, Riordan J, White R, Young L (2017) A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia. Intern Med J 47:491–500CrossRefPubMed Wong PKK, Bagga H, Barrett C, Hanrahan P, Johnson D, Katrib A, Leder K, Marabani M, Pentony P, Riordan J, White R, Young L (2017) A practical approach to vaccination of patients with autoimmune inflammatory rheumatic diseases in Australia. Intern Med J 47:491–500CrossRefPubMed

go back to reference Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barre syndrome. Proc Natl Acad Sci USA 101:11404–11409CrossRefPubMedPubMedCentral Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barre syndrome. Proc Natl Acad Sci USA 101:11404–11409CrossRefPubMedPubMedCentral

go back to reference Zlamy M, Almanzar G, Parson W, Schmidt C, Leierer J, Weinberger B, Jeller V, Unsinn K, Eyrich M, Wurzner R, Prelog M (2016) Efforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomy. Immun Ageing 13:3. https://doi.org/10.1186/s12979-016-0058-z CrossRefPubMedPubMedCentral Zlamy M, Almanzar G, Parson W, Schmidt C, Leierer J, Weinberger B, Jeller V, Unsinn K, Eyrich M, Wurzner R, Prelog M (2016) Efforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomy. Immun Ageing 13:3. https://​doi.​org/​10.​1186/​s12979-016-0058-z CrossRefPubMedPubMedCentral

go back to reference Zlamy M, Wurzner R, Holzmann H, Brandstatter A, Jeller V, Zimmerhackl LB, Prelog M (2010) Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy. Vaccine 28:8053–8060CrossRefPubMed Zlamy M, Wurzner R, Holzmann H, Brandstatter A, Jeller V, Zimmerhackl LB, Prelog M (2010) Antibody dynamics after tick-borne encephalitis and measles-mumps-rubella vaccination in children post early thymectomy. Vaccine 28:8053–8060CrossRefPubMed